Share
array:24 [ "pii" => "S2387020615000467" "issn" => "23870206" "doi" => "10.1016/j.medcle.2015.05.004" "estado" => "S300" "fechaPublicacion" => "2015-02-02" "aid" => "2888" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2013" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Med Clin. 2015;144:126-31" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 347 "formatos" => array:2 [ "HTML" => 303 "PDF" => 44 ] ] "Traduccion" => array:1 [ "es" => array:18 [ "pii" => "S0025775314001183" "issn" => "00257753" "doi" => "10.1016/j.medcli.2014.01.025" "estado" => "S300" "fechaPublicacion" => "2015-02-02" "aid" => "2888" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "subdocumento" => "rev" "cita" => "Med Clin. 2015;144:126-31" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1668 "formatos" => array:2 [ "HTML" => 1440 "PDF" => 228 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Revisión</span>" "titulo" => "Reacciones adversas a medicamentos en la cavidad oral" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "126" "paginaFinal" => "131" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Side effects of drugs on the oral cavity" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1357 "Ancho" => 995 "Tamanyo" => 202991 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Úlceras inducidas por aplicación local de fármacos.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Antonio Bascones-Martínez, Marta Muñoz-Corcuera, Cristina Bascones-Ilundain" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Antonio" "apellidos" => "Bascones-Martínez" ] 1 => array:2 [ "nombre" => "Marta" "apellidos" => "Muñoz-Corcuera" ] 2 => array:2 [ "nombre" => "Cristina" "apellidos" => "Bascones-Ilundain" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020615000467" "doi" => "10.1016/j.medcle.2015.05.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020615000467?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775314001183?idApp=UINPBA00004N" "url" => "/00257753/0000014400000003/v2_201706012044/S0025775314001183/v2_201706012044/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2387020615000509" "issn" => "23870206" "doi" => "10.1016/j.medcle.2015.05.008" "estado" => "S300" "fechaPublicacion" => "2015-02-02" "aid" => "3081" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Clin. 2015;144:132-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 161 "formatos" => array:2 [ "HTML" => 120 "PDF" => 41 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>" "titulo" => "Changes in viper bite poisonings" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "132" "paginaFinal" => "136" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Novedades en el envenenamiento por mordedura de víbora" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Cristina Martín, Santiago Nogué" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Cristina" "apellidos" => "Martín" ] 1 => array:2 [ "nombre" => "Santiago" "apellidos" => "Nogué" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775314005788" "doi" => "10.1016/j.medcli.2014.06.015" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775314005788?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020615000509?idApp=UINPBA00004N" "url" => "/23870206/0000014400000003/v1_201510132016/S2387020615000509/v1_201510132016/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020615000492" "issn" => "23870206" "doi" => "10.1016/j.medcle.2015.05.007" "estado" => "S300" "fechaPublicacion" => "2015-02-02" "aid" => "3022" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Med Clin. 2015;144:121-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 250 "formatos" => array:2 [ "HTML" => 150 "PDF" => 100 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Diagnosis and treatment</span>" "titulo" => "Non-celiac villous atrophy: More confusion or a new syndrome?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "121" "paginaFinal" => "125" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Atrofia vellositaria sin enfermedad celíaca: ¿un nuevo síndrome o más confusión?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1755 "Ancho" => 2500 "Tamanyo" => 378295 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Villus atrophy in a patient treated with olmesartan, who started to recover after suspending it.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Luis Téllez Villajos, Laura Crespo Pérez, Ana Cano Ruiz" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Luis" "apellidos" => "Téllez Villajos" ] 1 => array:2 [ "nombre" => "Laura" "apellidos" => "Crespo Pérez" ] 2 => array:2 [ "nombre" => "Ana" "apellidos" => "Cano Ruiz" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775314004059" "doi" => "10.1016/j.medcli.2014.05.022" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775314004059?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020615000492?idApp=UINPBA00004N" "url" => "/23870206/0000014400000003/v1_201510132016/S2387020615000492/v1_201510132016/en/main.assets" ] "en" => array:21 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Side effects of drugs on the oral cavity" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "126" "paginaFinal" => "131" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Antonio Bascones-Martínez, Marta Muñoz-Corcuera, Cristina Bascones-Ilundain" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Antonio" "apellidos" => "Bascones-Martínez" "email" => array:1 [ 0 => "antbasco@odon.ucm.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Marta" "apellidos" => "Muñoz-Corcuera" ] 2 => array:2 [ "nombre" => "Cristina" "apellidos" => "Bascones-Ilundain" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Departamento de Medicina y Cirugía Bucofacial, Facultad de Odontología, Universidad Complutense de Madrid, Madrid, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Reacciones adversas a medicamentos en la cavidad oral" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1357 "Ancho" => 995 "Tamanyo" => 233409 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Ulcers induced by the local application of drugs.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">When we talk about medications, “adverse reaction” or “adverse or undesirable event” is defined, according to the WHO, as an unexpected detrimental response that appears after the administration of a medication at the dosage normally used for the prophylaxis, diagnosis, and treatment of a disease or for the modification of a physiological function<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">1</span></a>.</p><p id="par0010" class="elsevierStylePara elsevierViewall">These adverse reactions can occur in many organs or systems and the oral cavity and its associated structures is just one example. The adverse events that appear in this area are heterogeneous because of the tissue where they appear and the clinical consequences they have for the patient<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">2</span></a>.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The most frequent adverse events that occur in the oral cavity can be classified as follows<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">3,4</span></a>:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1.</span><p id="par0020" class="elsevierStylePara elsevierViewall">Salivary gland alterations: xerostomia, ptyalism, swelling and pain.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2.</span><p id="par0025" class="elsevierStylePara elsevierViewall">Taste alterations.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3.</span><p id="par0030" class="elsevierStylePara elsevierViewall">Mucosal alterations: oral ulcerations or chemical burns, chemotherapy-induced mucositis, lichenoid reactions, erythema multiforme, pemphigus.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">4.</span><p id="par0035" class="elsevierStylePara elsevierViewall">Pigmentations: dental staining, oral mucosal pigmentations, hairy tongue.</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">5.</span><p id="par0040" class="elsevierStylePara elsevierViewall">Gingival enlargements.</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">6.</span><p id="par0045" class="elsevierStylePara elsevierViewall">Halitosis.</p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">7.</span><p id="par0050" class="elsevierStylePara elsevierViewall">Osteonecrosis.</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">8.</span><p id="par0055" class="elsevierStylePara elsevierViewall">Necrotising sialometaplasia.</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">9.</span><p id="par0060" class="elsevierStylePara elsevierViewall">Opportunistic infections.</p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel">10.</span><p id="par0065" class="elsevierStylePara elsevierViewall">Haemorrhagic diathesis.</p></li></ul></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Salivary gland alterations</span><p id="par0070" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Xerostomia</span> is defined as the subjective sensation of dry mouth. <span class="elsevierStyleItalic">Hyposialia</span> is defined as the decrease in salivary flow under conditions of rest. In order to be considered salivary hyposecretion, figures below 0.1-0.2 ml/min at rest or below 0.5-0.7 ml/min under stimulation must be found. This condition is one of the most frequent adverse drug events that occur in the oral cavity, with medications being the main cause of dry mouth<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">3</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0005">table 1</a>).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">Medications cause xerostomia through a range of mechanisms. One of the most important of these is sympathomimetic or anticholinergic action; the M3 muscarinic receptor mediates cholinergic-parasympathomimetic neurotransmission to the salivary glands, although this would not be the only receptor involved<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">5</span></a>.</p><p id="par0080" class="elsevierStylePara elsevierViewall">The groups of medications most commonly associated with xerostomia are antidepressants, antipsychotics, antihypertensives, antihistamines, antiarrhythmics and anticholinergics<a class="elsevierStyleCrossRefs" href="#bib0140"><span class="elsevierStyleSup">4,5</span></a>.</p><p id="par0085" class="elsevierStylePara elsevierViewall">Drug-induced <span class="elsevierStyleItalic">polysialia</span> or <span class="elsevierStyleItalic">ptyalism</span> is an increase in the salivary secretion rate. It is infrequent but clinical cases have been reported in relation to certain drugs. Parasympathomimetic medications are those most frequently involved. They cause salivary hypersecretion, either by direct action on acetylcholine receptors or through the inhibition of acetylcholinesterase<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">6</span></a>. Catecholamines and other sympathomimetic drugs may cause ptyalism through the stimulation of α and ß receptors<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">4</span></a>.</p><p id="par0090" class="elsevierStylePara elsevierViewall">Other drugs that may cause polysialia by direct action on the central nervous system are cocaine, reserpine, clonazepam or ketamine and, indirectly, morphine and digitalis drugs. Mercury, bromide and iodised compounds may have an effect on the salivary gland that increases the production of saliva<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">3</span></a>.</p><p id="par0095" class="elsevierStylePara elsevierViewall">Other drugs can cause <span class="elsevierStyleItalic">inflammation</span> and <span class="elsevierStyleItalic">pain</span> in the salivary gland. In some cases, they are associated with hypersensitivity, but in others, the pathogenesis is unclear, as it is related to the compound's pharmacokinetics and pharmacodynamics. The drugs associated with this effect are those derived from pyrazolone, antihypertensives, anti-ulcer drugs, antibiotics, iodides and antipsychotics<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">7</span></a>.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Taste alterations</span><p id="par0100" class="elsevierStylePara elsevierViewall">Drugs can cause loss of taste acuity (gustatory hypesthesia), distortion in the perception of the correct taste of a substance (dysgeusia) or loss of taste (ageusia). These disorders can occur in 3 ways: 1) the excretion of the drug or its metabolites in saliva, which interferes with the chemical composition of the saliva; 2) by affecting the transduction signal, and 3) by directly damaging the taste ridges or taste receptors<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">8</span></a>.</p><p id="par0105" class="elsevierStylePara elsevierViewall">The drugs most commonly associated with this problem include: angiotensin-converting enzyme (ACE) inhibitors, β-lactam antibiotics, biguanides, chlorhexidine, antithyroid drugs and opiates. Typically, captopril causes a salty taste and for enalapril, a sweet metallic taste<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">9</span></a>.</p><p id="par0110" class="elsevierStylePara elsevierViewall">These effects are reversible, although recovery takes several months after withdrawal of the drug<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">4</span></a>.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Oral mucosal alterations</span><p id="par0115" class="elsevierStylePara elsevierViewall">Oral mucosal <span class="elsevierStyleItalic">ulcerations</span> and <span class="elsevierStyleItalic">burns</span> occur when the patient uses a drug topically when its use is not topical or when the patient takes it in the wrong way. One of the most frequent cases is the “acetylsalicylic acid burn.” The acid may soothe dental pain when applied topically but it produces a superficial necrosis of the oral epithelium. Other medications that can cause ulcers are phenylbutazone, indomethacin, silver nitrate, hydrogen peroxide, isoproterenol and potassium chloride, as well as some antineoplastics (metothrexate, 5-fluorouracil or doxorubicin)<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">10,11</span></a> (<a class="elsevierStyleCrossRef" href="#fig0005">fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0120" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Chemotherapy-induced mucositis</span> appears as an inflammation and ulceration of the oral mucosa with formation of pseudomembranes and is associated with chemotherapy treatment. It can present different levels of severity and this, and its frequency depend on the type and dose of chemotherapy medication used, the age of the patient, the patient's haematological and nutritional status, and oral hygiene. It usually appears between the fourth and tenth day after initiating oncological treatment. On days 4-5, an erythema is observed and the patient does not tolerate spicy foods. On days 7-10, ulcerations appear that affect the patient's intake pattern<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">12,13</span></a>.</p><p id="par0125" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Lichenoid reactions</span> refer to the appearance of lesions in the oral mucosa, clinically and histologically similar to those of a lichen planus, but associated with the intake of a medication<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">14</span></a>. Currently, the drugs most often involved in this type of reactions are the non-steroidal anti-inflammatory drugs and ACE inhibitors. Lichenoid reactions can also appear with the intake of antihypertensives, psychiatric drugs or oral hypoglycaemic drugs<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">15</span></a> (<a class="elsevierStyleCrossRef" href="#fig0010">fig. 2</a>).</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0130" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Erythema multiforme</span> is a self-limiting, polymorphic, acute, mucocutaneous inflammatory disease that can affect the skin, oral mucosa, several mucous membranes or skin and mucosa. Its aetiology is unclear and there are several possible causes, including drugs. When the oral mucosa is affected, it typically affects the lips with serohaematic crust formation. Diagnosis is based on its sudden appearance, its relation with the previous intake of a drug and the appearance of the crusts on the lips<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">16</span></a> (<a class="elsevierStyleCrossRef" href="#fig0015">fig. 3</a>).</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia><p id="par0135" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Pemphigus</span> is an autoimmune disorder that occurs with the formation of intraepithelial blisters on the skin and mucosa, caused by the production of antibodies against specific epithelial cell junction proteins. Some drugs induce antibody formation that results in acantholysis through a mechanism identical to that found in pemphigus vulgaris. The clinical characteristics of this drug-induced pemphigus are similar to those of pemphigus vulgaris. Depending on their chemical structure, these drugs can be divided into 2 groups<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">3</span></a>:<ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0055"><span class="elsevierStyleLabel">-</span><p id="par0140" class="elsevierStylePara elsevierViewall">Medications that contain the sulfhydryl radical or thiol drugs. For example, penicillamine or ACE inhibitors (captopril or enalapril). The sulfhydryl groups are similar in structure to desmoglein-3, one of the antigens involved in pemphigus, and they trigger a cross immune response.</p></li><li class="elsevierStyleListItem" id="lsti0060"><span class="elsevierStyleLabel">-</span><p id="par0145" class="elsevierStylePara elsevierViewall">Non-thiol drugs. These contain an active amino group in their molecules. They produce acantholysis via an autoimmune mechanism coinciding with that of pemphigus.</p></li></ul></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Pigmentations</span><p id="par0150" class="elsevierStylePara elsevierViewall">Many drugs can cause <span class="elsevierStyleItalic">dental staining</span> (<a class="elsevierStyleCrossRef" href="#tbl0010">table 2</a>), both intrinsic and extrinsic. Extrinsic stains are located on the tooth surface and can be removed in different ways. One drug that can cause these stains is chlorhexidine, when used continuously<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">17</span></a>.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0155" class="elsevierStylePara elsevierViewall">Intrinsic stains are located inside the dental structure. Some, but not all, intrinsic stains can only be treated by whitening. These stains are caused by the administration of drugs during the tooth calcification period. Some of the drugs involved are tetracyclines and fluorine. Tetracyclines have an affinity for calcium and behave as chelating agents, forming a calcium tetracycline-orthophosphate complex in the hydroxyapatite crystals that is incorporated into the tooth structure during the mineralisation periods in tooth development. The teeth affected present yellowish or greyish-brown bands. Fluorine interferes in the ameloblastic function, affecting the formation of the adamantine substance matrix and their calcification. Above all, it affects permanent dentition. Lesions are usually bilateral and symmetric, in the form of horizontal stripes<a class="elsevierStyleCrossRefs" href="#bib0125"><span class="elsevierStyleSup">1,18</span></a>.</p><p id="par0160" class="elsevierStylePara elsevierViewall">Drug-related <span class="elsevierStyleItalic">oral mucosal pigmentations</span> are superficial and the mechanism that causes them is unknown. They normally disappear when the drug is withdrawn. Some of the medications that can cause them are antimalarial drugs, chlorpromazine, minocycline or cisplatin<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">3,4</span></a>.</p><p id="par0165" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Hairy tongue</span> is a benign disorder of the tongue that is characterised by the hypertrophy of the filiform ridges, resembling short hairs, and a colouring that goes from yellowish-white to black, depending on diet, oral hygiene, tobacco consumption and the presence of colonies of chromogenic bacteria. It is usually associated with the intake of antibiotics over long periods of time, is located at the back of the tongue, and may cause a burning sensation and halitosis<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">4</span></a>.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Gingival enlargement</span><p id="par0170" class="elsevierStylePara elsevierViewall">This refers to an increase in the size of gingival tissues caused by an increase in extracellular matrix production, mainly collagen, and in the number of cellular components<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">1</span></a>. It is associated with other factors, such as individual susceptibility and the presence of chronic inflammation caused by dental plaque. A histological exam shows a pronounced enlargement of the gingival connective tissue associated with an excessive well-differentiated growth of the fibrous tissue. An accumulation of mature, dense collagen fibres and fibroblasts widely distributed inside the chorion is observed. Systemic treatments associated with gingival enlargement can be divided into 3 groups (<a class="elsevierStyleCrossRef" href="#tbl0015">table 3</a>)<a class="elsevierStyleCrossRefs" href="#bib0140"><span class="elsevierStyleSup">4,19,20</span></a>:<ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0065"><span class="elsevierStyleLabel">-</span><p id="par0175" class="elsevierStylePara elsevierViewall">Anticonvulsants or antiepileptics (phenytoin, diphenylhydantoin).</p></li><li class="elsevierStyleListItem" id="lsti0070"><span class="elsevierStyleLabel">-</span><p id="par0180" class="elsevierStylePara elsevierViewall">Immunosuppressants (cyclosporin A).</p></li><li class="elsevierStyleListItem" id="lsti0075"><span class="elsevierStyleLabel">-</span><p id="par0185" class="elsevierStylePara elsevierViewall">Calcium channel blockers (nifedipine, verapamil, amlodipine).</p></li></ul></p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0190" class="elsevierStylePara elsevierViewall">These drugs are structurally different but have in common the action of inhibiting the cellular calcium uptake, a mechanism that is considered to be involved in the pathogenesis of gingival enlargements. From the clinical point of view, a progressive increase of the gum occurs, starting at the interdental ridges and appearing as firm, lobular masses that may cover the crown of the tooth. It is more frequent in the buccal area of anterior teeth<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">21</span></a> (<a class="elsevierStyleCrossRef" href="#fig0020">fig. 4</a>).</p><elsevierMultimedia ident="fig0020"></elsevierMultimedia></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Halitosis</span><p id="par0195" class="elsevierStylePara elsevierViewall">Halitosis is bad breath. It can be caused by different factors such as bad oral hygiene, oral and dental infections, the intake of certain foods, some systemic diseases, or as an adverse event after the intake of certain medications. Isosorbide dinitrate, dimethyl sulfoxide or disulfiram can cause halitosis directly or indirectly as they can cause xerostomia<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">4</span></a>.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Osteonecrosis</span><p id="par0200" class="elsevierStylePara elsevierViewall">This is a rare clinical entity described as an adverse event of treatment with certain drugs, especially bisphosphonates and, particularly, following their intravenous administration. It is associated with a blood supply alteration or an inhibition of osteogenesis and an increase in the apoptosis of osteocytes<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">1</span></a>. It can be defined as an “area of exposed bone that persists for more than 8 weeks in the absence of prior radiation and/or metastasis in the mandible.” In order to diagnose bisphosphonate-induced osteonecrosis, the clinical features should meet 3 requirements<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">22</span></a>:<ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0080"><span class="elsevierStyleLabel">-</span><p id="par0205" class="elsevierStylePara elsevierViewall">Current or prior use of bisphosphonate.</p></li><li class="elsevierStyleListItem" id="lsti0085"><span class="elsevierStyleLabel">-</span><p id="par0210" class="elsevierStylePara elsevierViewall">Presence of exposed or necrotic bone in the maxillofacial region that persists and does not heal in 8 weeks.</p></li><li class="elsevierStyleListItem" id="lsti0090"><span class="elsevierStyleLabel">-</span><p id="par0215" class="elsevierStylePara elsevierViewall">Absence of radiotherapy in the maxillary bones.</p></li></ul></p><p id="par0220" class="elsevierStylePara elsevierViewall">The aethiopathogenesis is unknown, but some related factors have been described, such as alteration of immunity and repair mechanisms due to neoplasia, vascular compromise, low bone turnover rate, bisphosphonate bone toxicity and biophosphate toxicity of soft tissues<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">22</span></a>.</p><p id="par0225" class="elsevierStylePara elsevierViewall">There are 3 clinical stages of bisphosphonate-induced osteonecrosis<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">23</span></a>:<ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0095"><span class="elsevierStyleLabel">-</span><p id="par0230" class="elsevierStylePara elsevierViewall">Stage I: presence of exposed or necrotic bone in asymptomatic patients without evidence of infection.</p></li><li class="elsevierStyleListItem" id="lsti0100"><span class="elsevierStyleLabel">-</span><p id="par0235" class="elsevierStylePara elsevierViewall">Stage II: presence of exposed or necrotic bone in patients with pain and evident signs of infection.</p></li><li class="elsevierStyleListItem" id="lsti0105"><span class="elsevierStyleLabel">-</span><p id="par0240" class="elsevierStylePara elsevierViewall">Stage III: presence of exposed or necrotic bone in patients with pain, infection and one or more of the following signs: pathological fracture, extraoral fistula or osteolisis extending to the lower edge.</p></li></ul></p><p id="par0300" class="elsevierStylePara elsevierViewall">Bisphosphonates reduce the bone turnover rate by inhibiting osteoclastic activity. Once deposited on the bone surface, bisphosphonates are internalised by osteoclasts, causing interruption of bone resorption. Moreover, they have antitumour and antiangiogenic effects. These drugs are used in the treatment of osteoporosis and other metabolic bone diseases. However, the greatest risk of osteonecrosis seems to appear in cancer patients. Tumours like multiple myeloma or breast carcinoma tend to involve the skeleton. Treatment with bisphosphonates significantly reduces the metastatic and local dissemination of these skeletal lesions, as well as the associated morbidity and mortality. More than 90% of the published cases of bisphosphonate-induced osteonecrosis occurred in the context of cancer treatment<a class="elsevierStyleCrossRefs" href="#bib0230"><span class="elsevierStyleSup">22,23</span></a>.</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Necrotising sialometaplasia</span><p id="par0250" class="elsevierStylePara elsevierViewall">Necrotising sialometaplasia is another drug-related adverse oral reaction that is caused by the injection of a vasoconstrictor (associated with local anaesthetics) in the palate (<a class="elsevierStyleCrossRef" href="#fig0025">fig. 5</a>). It is defined as a necrotising inflammatory reaction that affects minor salivary glands in the hard palate. It is a rare benign process that resolves spontaneously within 4-10 weeks after onset, without leaving functional or anatomic sequelae. It appears as a crater-shaped ulcer, with indurated and well-defined edges, generally unilateral, and it can be asymptomatic or painful. The subjacent bone is not usually affected. Its importance resides in its similarity to a malignant ulcer, so a biopsy needs to be performed to confirm diagnosis<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">24</span></a>.</p><elsevierMultimedia ident="fig0025"></elsevierMultimedia></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Opportunistic infections</span><p id="par0255" class="elsevierStylePara elsevierViewall">Treatment with systemic drugs, such as glucocorticosteroids, broad-spectrum antibiotics, immunosuppressants and antineoplastics, may alter the oral flora, giving rise to a predisposition to the appearance of oral fungal or bacterial infections. One of the most frequent opportunistic infections is that caused by <span class="elsevierStyleItalic">Candida albicans</span>. It can appear in different forms: acute atrophic, chronic atrophic or acute pseudomembranous (muguet). The latter is characterised by the presence of whitish plaques that can be detached by scraping, leaving a painful, red, ulcerated, surface<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">3,4</span></a>.</p><p id="par0260" class="elsevierStylePara elsevierViewall">The drugs that produce xerostomia favour the appearance of oral infections, such as candidiasis or suppurative parotitis. Furthermore, the prolonged use of broad-spectrum antibiotics may cause the appearance of candidiasis. Another favourable mechanism for the appearance of opportunistic infections is the modification of the host defensive response. A clear example is neutropenia, caused by the depression of spinal function induced by the cytotoxic drugs used in cancer treatment. Another mechanism is the immune suppression that takes place in patients infected with human immunodeficiency virus or under chronic treatment with corticosteroids<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">3,4</span></a>.</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Haemorrhagic diathesis</span><p id="par0265" class="elsevierStylePara elsevierViewall">Possible intraoral haemorrhages constitute another disorder that can be induced by the intake of certain drugs (<a class="elsevierStyleCrossRef" href="#tbl0020">table 4</a>). These haemorrhages are be associated with several factors, such as thrombocytopoenia, defective vascular integrity or coagulation alterations<a class="elsevierStyleCrossRefs" href="#bib0125"><span class="elsevierStyleSup">1,3</span></a>.</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0270" class="elsevierStylePara elsevierViewall">Drugs can cause thrombocytopenia, either by spinal toxicity (cytotoxic drugs or thiazide diuretics) or by peripheral platelet destruction via the immune mechanism (quinine, quindine or methyldopa). Clinically, this appears in the form of petechiae that appear following minimal trauma to the lateral edge of the tongue, lips, buccal mucosa and the junction of the hard palate and soft palate<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">3</span></a>.</p><p id="par0275" class="elsevierStylePara elsevierViewall">Certain drugs can cause gingival haemorrhage directly or indirectly. The gum may bleed spontaneously after brushing or other activities such as mastication. This can occur in patients under treatment with anticoagulants like heparin, acenocoumarol or warfarin. Anticoagulant drugs that are Vitamin K antagonists interfere with the production of vitamin K-dependent coagulation factors (II, VII, IX and X)<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">1</span></a>.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Conclusion</span><p id="par0280" class="elsevierStylePara elsevierViewall">As we have said, a wide number of drugs can cause several adverse events in the buccal cavity. The most frequent events are xerostomia, taste alterations, gingival enlargement and mucositis caused by oncological treatment.</p><p id="par0285" class="elsevierStylePara elsevierViewall">It is important for the clinician to obtain a complete medical record of the medications the patient takes, including prescription drugs, over-the-counter drugs and dietary supplements. Thus, the clinician will be able to individually prevent, diagnose and treat adverse effects occurring in the oral cavity.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Conflict of interest</span><p id="par0290" class="elsevierStylePara elsevierViewall">The authors declare that there are no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:19 [ 0 => array:3 [ "identificador" => "xres568381" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec585735" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres568382" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec585736" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Salivary gland alterations" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Taste alterations" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Oral mucosal alterations" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Pigmentations" ] 9 => array:2 [ "identificador" => "sec0030" "titulo" => "Gingival enlargement" ] 10 => array:2 [ "identificador" => "sec0035" "titulo" => "Halitosis" ] 11 => array:2 [ "identificador" => "sec0040" "titulo" => "Osteonecrosis" ] 12 => array:2 [ "identificador" => "sec0045" "titulo" => "Necrotising sialometaplasia" ] 13 => array:2 [ "identificador" => "sec0050" "titulo" => "Opportunistic infections" ] 14 => array:2 [ "identificador" => "sec0055" "titulo" => "Haemorrhagic diathesis" ] 15 => array:2 [ "identificador" => "sec0060" "titulo" => "Conclusion" ] 16 => array:2 [ "identificador" => "sec0065" "titulo" => "Conflict of interest" ] 17 => array:2 [ "identificador" => "xack191808" "titulo" => "Acknowledgements" ] 18 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2013-11-13" "fechaAceptado" => "2014-01-30" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec585735" "palabras" => array:3 [ 0 => "Drugs" 1 => "Adverse reaction" 2 => "Oral cavity" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec585736" "palabras" => array:3 [ 0 => "Fármacos" 1 => "Reacción adversa" 2 => "Cavidad bucal" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Although drugs are the most powerful therapeutic tools we have for improving the quality of life of the population, their use is not free of adverse effects. Today there are many polymedicated patients, and it is difficult to find the cause of their adverse effects that increase exponentially when more than 4 drugs are combined.</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">There are a large number of drugs that can result in numerous adverse effects in the oral cavity. The most common are xerostomia, altered taste, gingival enlargement and mucositis caused by cancer treatment. We also review other disorders of the salivary glands, oral mucosal changes, pigmentations, halitosis, osteonecrosis, opportunistic infections and bleeding diathesis.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">A pesar de que los fármacos son la herramienta terapéutica más potente de la que disponemos para mejorar la calidad de vida de la población, su uso no está exento de efectos adversos. Hoy en día son muchos los pacientes polimedicados, siendo complicado encontrar la causa de los efectos adversos generados por la medicación y aumentando estos de manera exponencial cuando se combinan más de 4 fármacos.</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Existe un amplio número de fármacos que pueden dar lugar a numerosos efectos adversos en la cavidad bucal. Los más frecuentes son la xerostomía, las alteraciones del gusto, el agrandamiento gingival y las mucositis producidas por el tratamiento oncológico. También se revisan otras alteraciones de las glándulas salivales, las alteraciones de la mucosa oral, las pigmentaciones, la halitosis, la osteonecrosis, las infecciones oportunistas y las diátesis hemorrágicas.</p></span>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Bascones-Martínez A, Muñoz-Corcuera M, Bascones-Ilundain C. Reacciones adversas a medicamentos en la cavidad oral. Med Clin (Barc). 2015;144:126–131.</p>" ] ] "multimedia" => array:9 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1357 "Ancho" => 995 "Tamanyo" => 233409 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Ulcers induced by the local application of drugs.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 560 "Ancho" => 997 "Tamanyo" => 107418 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Lichenoid reaction in the buccal mucosa.</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1017 "Ancho" => 902 "Tamanyo" => 120570 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Drug-induced multiform exudative erythema.</p>" ] ] 3 => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 746 "Ancho" => 995 "Tamanyo" => 156427 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Sodium nifedipine-induced gingival enlargement.</p>" ] ] 4 => array:7 [ "identificador" => "fig0025" "etiqueta" => "Figure 5" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr5.jpeg" "Alto" => 747 "Ancho" => 997 "Tamanyo" => 129200 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Necrotising sialometaplasia caused by injection of local anaesthetics with vasoconstrictor to the palate.</p>" ] ] 5 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar1025" class="elsevierStyleSimplePara elsevierViewall">HIV: Human immunodeficiency virus.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Antidepressants \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Amphetamines \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Anticholinergics \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Antihistamines \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Antihypertensives \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Anti-migraine agents \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Antipsychotics \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Appetite suppressants \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Anxiolytics \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Drugs of abuse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hypnotics \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Diuretics \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Muscle relaxants \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Anti-HIV medications \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Opiates \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab925003.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Groups of medications that can cause xerostomia.</p>" ] ] 6 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Drug \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Colour \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Chlorhexidine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Yellowish-greyish-brown \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Chlortetracycline \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Grey-brown \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Ciprofloxacin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Green \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Amoxicillin-clavulanic acid \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Yellow or greyish-brown \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Doxycycline \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Yellow \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Iron salts \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Black \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Fluoride \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">White-brown \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Isoproterenol \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Chalk white \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Minocycline \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Grey-black \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Tetracyclines \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Yellowish-greyish-brown \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Potassium permanganate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Purple-black \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Silver nitrate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Grey \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab925004.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Drugs and the colours they can cause in dental staining.</p>" ] ] 7 => array:7 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Amlodipine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Nitrendipine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Cotrimazole \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Norethisterone \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Erythromycin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Cyclosporine \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Diltiazem \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Diphenoxylate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Mestranol \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Felodipine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ethosuximide \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Phenobarbital \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Lacidipine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Interferon-alpha \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Primidone \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Nifedipine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ketoconazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Sertraline \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Lamotrigine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Topiramate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Contraceptives \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Valproate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Phenytoin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Lithium \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Verapamil \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Mephenytoin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Vigabatrin \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab925002.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Drugs that can cause gingival enlargement.</p>" ] ] 8 => array:7 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Sulphonamides \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Quinine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Quinidine \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Diuretics \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Thiazides \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Antineoplastic agents \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Heparin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Acenocoumarol \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Warfarin \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Allopurinol \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Methyldopa \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Digital \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab925005.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Drugs that can cause haemorrhagic diathesis.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:24 [ 0 => array:3 [ "identificador" => "bib0125" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral manifestations of adverse drug reactions: guidelines" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Femiano" 1 => "A. Lanza" 2 => "C. Buonaiuto" 3 => "F. Gombos" 4 => "R. Rullo" 5 => "V. Festa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2008.02637.x" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2008" "volumen" => "22" "paginaInicial" => "681" "paginaFinal" => "691" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18331319" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0130" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drugs and oral disorders" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "T.D. Rees" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Periodontol 2000" "fecha" => "1998" "volumen" => "18" "paginaInicial" => "21" "paginaFinal" => "36" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10200710" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0135" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adverse drug reactions in the orofacial region" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Scully" 1 => "J.V. Bagan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Crit Rev Oral Biol Med" "fecha" => "2004" "volumen" => "15" "paginaInicial" => "221" "paginaFinal" => "239" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15284187" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0140" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Current opinion on drug-induced oral reactions: a comprehensive review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Abdollahi" 1 => "R. Rahimi" 2 => "M. Radfar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Contemp Dent Pract" "fecha" => "2008" "volumen" => "9" "paginaInicial" => "1" "paginaFinal" => "15" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18997910" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0145" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug effects on salivary glands: dry mouth" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "C. Scully" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Oral Dis" "fecha" => "2003" "volumen" => "9" "paginaInicial" => "165" "paginaFinal" => "176" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12974516" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0150" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical-therapeutic management of drooling: review and update" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J. Silvestre-Rangil" 1 => "F.J. Silvestre" 2 => "A. Puente-Sandoval" 3 => "J. Requeni-Bernal" 4 => "J.M. Simó-Ruiz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Med Oral Patol Oral Cir Bucal" "fecha" => "2011" "volumen" => "16" "paginaInicial" => "e763" "paginaFinal" => "e766" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21743406" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0155" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A review of drug-induced oral reactions" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Abdollahi" 1 => "M. Radfar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Contemp Dent Pract" "fecha" => "2003" "volumen" => "4" "paginaInicial" => "10" "paginaFinal" => "31" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12595930" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0160" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Idiopathic dysgeusia; an open trial of alpha lipoic acid (ALA) therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F. Femiano" 1 => "C. Scully" 2 => "F. Gombos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1054/ijom.2002.0276" "Revista" => array:6 [ "tituloSerie" => "Int J Oral Maxillofac Surg" "fecha" => "2002" "volumen" => "31" "paginaInicial" => "625" "paginaFinal" => "628" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12521319" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0165" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Disturbances of taste and smell induced by drugs" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "B.H. Ackerman" 1 => "N. Kasbekar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pharmacotherapy" "fecha" => "1997" "volumen" => "17" "paginaInicial" => "482" "paginaFinal" => "496" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9165552" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0170" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aspirin burn of the oral cavity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "T. Dellinger" 1 => "H. Livingston" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Ann Pharmacol" "fecha" => "1998" "volumen" => "32" "paginaInicial" => "1107" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0175" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral medicine – update for the dental practicioner. Mouth ulcers of more serious connotation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Scully" 1 => "D.H. Felix" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/sj.bdj.4812805" "Revista" => array:6 [ "tituloSerie" => "Br Dent J" "fecha" => "2005" "volumen" => "199" "paginaInicial" => "339" "paginaFinal" => "343" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16184105" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0180" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Protocolo diagnóstico y terapéutico de la mucositis por quimioterapia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "I. Palacio" 1 => "M.T. Velasco" 2 => "N. Gonzalez" 3 => "A. Jimenez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Medicine (Baltimore)" "fecha" => "2001" "volumen" => "8" "paginaInicial" => "3131" "paginaFinal" => "3133" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0185" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral mucositis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Scully" 1 => "S. Sonis" 2 => "P.D. Diz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1601-0825.2006.01258.x" "Revista" => array:6 [ "tituloSerie" => "Oral Dis" "fecha" => "2006" "volumen" => "12" "paginaInicial" => "229" "paginaFinal" => "241" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16700732" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0190" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liquen plano oral, reacciones liquenoides y tratamientos odontológicos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "V. Miguel" 1 => "E. Moreno" 2 => "G. Esparza" 3 => "R. Cerero" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Prof Dent" "fecha" => "2004" "volumen" => "3" "paginaInicial" => "123" "paginaFinal" => "127" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0195" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral lichen planus and lichenoid reactions: ethiopathogenesis, diagnosis, management and malignant transformation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.B. Ismail" 1 => "S.K. Kumar" 2 => "R.B. Zain" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Oral Sci" "fecha" => "2007" "volumen" => "49" "paginaInicial" => "89" "paginaFinal" => "106" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17634721" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0200" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Erythema multiforme: diagnosis, clinical manifestations and treatment in a retrospective study of 22 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.M. Sanchis" 1 => "J.V. Bagán" 2 => "C. Gavaldá" 3 => "J. Murillo" 4 => "J.M. Diaz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0714.2010.00912.x" "Revista" => array:6 [ "tituloSerie" => "J Oral Pathol Med" "fecha" => "2010" "volumen" => "39" "paginaInicial" => "747" "paginaFinal" => "752" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20738747" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0205" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antisépticos orales. Revisión de la literatura y perspectiva actual" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Bascones" 1 => "S. Morante" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Av Periodon Implantol" "fecha" => "2006" "volumen" => "18" "paginaInicial" => "31" "paginaFinal" => "59" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0210" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Minocycline and oral pigmentation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.M. Cockings" 1 => "N.W. Savage" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aust Dent J" "fecha" => "1998" "volumen" => "43" "paginaInicial" => "14" "paginaFinal" => "16" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9583219" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0215" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral problems and genetic aspects of individuals with epilepsy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "T.M. Hassell" 1 => "A.P. Burtner" 2 => "D. McNeal" 3 => "R.G. Smith" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Periodontol 2000" "fecha" => "1994" "volumen" => "6" "paginaInicial" => "68" "paginaFinal" => "78" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9673171" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0220" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Agrandamiento gingival inducido por nifedipino. Reporte de un caso" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A.J. Díaz" 1 => "L. Arévalo" 2 => "M.A. Fonseca" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Duazary" "fecha" => "2009" "volumen" => "6" "paginaInicial" => "51" "paginaFinal" => "55" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0225" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of drug-induced gingival enlargement: aesthetic and functional considerations" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "P.M. Camargo" 1 => "P.R. Melnick" 2 => "F.Q. Pirih" 3 => "R. Lagos" 4 => "H.H. Takei" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Periodontol 2000" "fecha" => "2001" "volumen" => "27" "paginaInicial" => "131" "paginaFinal" => "138" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11551304" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0230" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral bisphosphonates-related osteonecrosis of the jaws: clinical characteristics of a series of 20 cases in Spain" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Diniz-Freitas" 1 => "J.L. López-Cedrún" 2 => "J. Fernández-Sanromán" 3 => "A. García-García" 4 => "J. Fernández-Feijoo" 5 => "P. Diz-Dios" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Med Oral Patol Oral Cir Bucal" "fecha" => "2012" "volumen" => "17" "paginaInicial" => "e751" "paginaFinal" => "e758" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22549688" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0235" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteonecrosis de los maxilares asociada a bifosfonatos: revisión sistemática" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "E.A. Escobar-López" 1 => "J. López-López" 2 => "M.S. Marqués-Soares" 3 => "E. Chimenos-Küstner" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Av Odontoestomatol" "fecha" => "2007" "volumen" => "23" "paginaInicial" => "91" "paginaFinal" => "101" ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0240" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Case report of necrotizing sialometaplasia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Bascones-Martínez" 1 => "M. Muñoz-Corcuera" 2 => "R. Cerero-Lapiedra" 3 => "J. Bascones-Ilundáin" 4 => "G. Esparza-Gómez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Med Oral Patol Oral Cir Bucal" "fecha" => "2011" "volumen" => "16" "paginaInicial" => "e700" "paginaFinal" => "e703" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21217621" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack191808" "titulo" => "Acknowledgements" "texto" => "<p id="par0295" class="elsevierStylePara elsevierViewall">The authors would like to thank Dr. Nagore Ambrosio-Elejalde for her cooperation in the drafting of this article.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000014400000003/v1_201510132016/S2387020615000467/v1_201510132016/en/main.assets" "Apartado" => array:4 [ "identificador" => "44147" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000014400000003/v1_201510132016/S2387020615000467/v1_201510132016/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020615000467?idApp=UINPBA00004N" ]
